[{"AccountsPayableCurrent_0_Q1_USD":6400000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3768000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":163000.0,"AccruedBonusesCurrent_0_Q1_USD":2014000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":20000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-17000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":91000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2653000.0,"OtherLiabilitiesCurrent_0_Q1_USD":41000.0,"ShortTermInvestments_0_Q1_USD":35957000.0,"AllowanceForDoubtfulOtherReceivablesCurrent_0_Q1_USD":3500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":45712000.0,"OtherAssetsCurrent_0_Q1_USD":3504000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":549000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":91000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":420000.0,"InvestmentIncomeInterest_1_Q1_USD":306000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":533000.0,"OperatingLeaseExpense_1_Q1_USD":1400000.0,"StockIssued1_1_Q1_USD":66000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-4664000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":1720000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-1864000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":106000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":69705000.0,"ShortTermLeaseCost_1_Q1_USD":100000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":26678000.0,"RestrictedCashNoncurrent_0_Q1_USD":89000.0,"RestrictedCash_0_Q1_USD":100000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_1_Q1_USD":20135000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":5676000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":97000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":41000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":24496000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":44000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":21597000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"Investments_0_Q1_USD":37700000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q1_USD":-7000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":139000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":41000.0,"FinanceLeaseInterestExpense_1_Q1_USD":100000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":18734000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":69767000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5535000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":224000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1_Q1_USD":326000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":9922000.0,"NetIncomeLoss_1_Q1_USD":-4705000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":4686000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":13742000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":306000.0,"LiabilitiesCurrent_0_Q1_USD":18125000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":150265000.0,"Liabilities_0_Q1_USD":39813000.0,"InventoryNet_0_Q1_USD":7282000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-59000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":717000.0,"GrossProfit_1_Q1_USD":16756000.0,"Depreciation_1_Q1_USD":500000.0,"CommonStockValue_0_Q1_USD":493774000.0,"CommonStockSharesOutstanding_0_Q1_shares":44963000.0,"CommonStockSharesIssued_0_Q1_shares":44963000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":45623000.0,"AssetsCurrent_0_Q1_USD":116537000.0,"Assets_0_Q1_USD":150265000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":62000.0,"AccountsReceivableNetCurrent_0_Q1_USD":24171000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.1,"NonoperatingIncomeExpense_1_Q1_USD":371000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-383384000.0,"StockholdersEquity_0_Q1_USD":110452000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":105000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":67000.0,"InventoryWorkInProcess_0_Q1_USD":617000.0,"InventoryRawMaterials_0_Q1_USD":6576000.0,"InventoryFinishedGoods_0_Q1_USD":89000.0,"IncreaseDecreaseInReceivables_1_Q1_USD":-7997000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":0.0,"IncreaseDecreaseInInventories_1_Q1_USD":466000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":223000.0,"Revenues_1_Q1_USD":26678000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":196000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":18069000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":3763000.0,"OperatingIncomeLoss_1_Q1_USD":-5076000.0,"OperatingExpenses_1_Q1_USD":21832000.0,"InterestExpense_1_Q1_USD":2000.0,"CommonStockSharesAuthorized_0_Q1_shares":75000000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":6149000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":44924000.0,"ShareBasedCompensation_1_Q1_USD":3768000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":0.0,"Ticker":"VCEL","CIK":"887359","name":"VERICEL CORP","OfficialName":"Vericel Corporation Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1756775066.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]